Azelastine Nasal Spray for Prevention of SARS-CoV-2 Infections

This randomized clinical trial evaluates the efficacy of azelastine as a preexposure prophylaxis against SARS-CoV-2 and other respiratory pathogens.

does azelastine nasal spray prevent COVID-19?

Unfortunately, probably not.

Howard G. Smith MD, AM on Instagram: "Allergy Nasal Spray Kills Cold and CoVid Viruses Azelastine nasal spray, marketed as Astepro but also available as a generic, can reduce your chances of developing a CoVid infection by a factor of 3 and cut your chances of developing a common cold by a factor of 3.5. German researchers at Saarland University recently published their double-blind, placebo-controlled study of 450 participants in the JAMA Internal Medicine Journal. Half the subjects received azelastine 0.1% nasal spray three times a day for 56 days. The control subjects used a similarly-appearing but inactive nasal spray. Respiratory infections were confirmed using PCR analyses. The results showed that only 2.2% of the azelestine sprayers developed CoVid compared with 6.7% of controls. Only 1.8% of azelestine sprayers developed rhinovirus infections compared with 6.3% of controls. Generic azelastine spray is a prescription medication. Astepro Spray, the same medication, is available over-the-counter. If you think you might benefit, give it a try. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2838335 #azelastine #astepro #allergy #CoVid #rhinovirus #commoncold"

Azelastine nasal spray, a prescription medication, has been found to reduce the risk of developing CoVid and common cold by a factor of 3. A study published in JAMA Internal Medicine, conducted by researchers at Saarland University, found that participants who used the nasal spray had a significantly lower risk of developing respiratory infections compared to those who did not use the spray.

Onderzoek wijst uit: met deze neusspray heb je drie keer minder kans op corona

Wist je dat een eenvoudige neusspray je deze herfst en winter misschien wel kan beschermen tegen het coronavirus? Duitse onderzoekers van Saarland University publiceerden hierover een nieuwe studie in ‘JAMA Internal Medicine’. De spray bleek ook effectief tegen andere virussen.

OTC nasal spray seemed to cut COVID infections by 67% in mid-sized trial

The Phase 2 trial is not definitive, but it comes as vaccine access is severely restricted.

Covid infection may be prevented with a common nasal antihistamine spray, trial shows

The over-the-counter antihistamine works against a range of respiratory infections, including Covid, flu and RSV, according to researchers.

#Azelastine Nasal #Spray for #Prevention of #SARS-CoV-2 Infections A Phase 2 #RCT

Existing antihistamine drugs show effectiveness against COVID-19 virus in cell testing - UF Health

Three common antihistamine medications have been found in preliminary tests to inhibit infection of cells by the coronavirus that causes COVID-19, University…